|Address||1F, Wooyoung Technocenter, 144, Achasan-ro, Seongdong-gu, Seoul, 04783, Korea|
BioSewoom, Inc. is a medical device manufacturer developing and producing in-vitro diagnostics for molecular diagnostics. We are specialized in molecular genetic test for the detection of dangerous pathogens, hereditary diseases, or genetic mutation. Our strong technology and expertise have an unrivaled competitiveness in this field domestically and internationally. BioSewoom aims to provide the highest quality products and customer experience by excelling in all areas of customer relations, product design, device production, quality control, and research support. In line with the rapidly changing world, we aim to provide the best products to our clients with best quality through the expertise process of Research and Development and the best human resources. In order to contribute to the improvement of the quality of human life, we are leading this field with a high global competitiveness in the turbulent world market. Biosewoom ,Inc complies with the legal requirements of GMP and ISO13485: 2016.
Real-Q Direct SARS-CoV-2 Detection Kit is an in vitro diagnostic device that qualitatively detects the COVID19 virus gene from the nasopharyngeal smear of a suspected respiratory infection patient using Real-time RT-PCR in 70min. This product is a diagnostic reagent that has been officially approved by the KMFDS.
Real-Q Direct SARS-CoV-2 FluA/FluB Detection Kit is an in vitro diagnostic device that qualitatively detects the COVID19, Influenza A and Influenza B Virus gene from the nasopharyngeal smear of a suspected respiratory infection patient using Real-time RT-PCR in70min. This product is a diagnostic reagent that has been officially approved by the KMFDS.